Literature DB >> 3612180

Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

J W Carnwath, D M Shotton.   

Abstract

We have used light microscopic histomorphometry to quantify the developmental histopathological changes induced by muscular dystrophy in the soleus and extensor digitorum longus (EDL) muscles of the mdx mouse. We find that this X-linked disease exhibits early fibre necrosis with foci of invasive cells, clustering of affected fibres, hyaline fibres, and, in the mixed soleus muscle, a progressive increase in the proportion of type 1 fibres, the mdx soleus containing 58 +/- 5% type 1 fibres by 26 weeks, compared with 27 +/- 4% in control C57BL/10 ScSn mice. This increase is not due to atrophy or slow axon reinnervation of type 2 fibres. Although only 5% of all original fibres survive by 26 weeks in the EDL, the diseased mdx fibres are continuously and successfully replaced by new fibres with internal nuclei, the affected mice thus avoiding the end-stage histopathology and physical disability characteristic of the X-linked human Duchenne and Emery-Dreifuss muscular dystrophies. Homozygous mdx mice share the life expectancy of normal C57BL/10 mice and appear behaviourly normal. The mdx mouse is therefore an excellent mammalian model in which to study the processes of muscle fibre degeneration and regeneration.

Entities:  

Mesh:

Year:  1987        PMID: 3612180     DOI: 10.1016/0022-510x(87)90219-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  89 in total

1.  Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice.

Authors:  C Collet; B Allard; Y Tourneur; V Jacquemond
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

2.  Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF.

Authors:  D J Garry; A Meeson; J Elterman; Y Zhao; P Yang; R Bassel-Duby; R S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

4.  Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.

Authors:  G S Lynch; R T Hinkle; J S Chamberlain; S V Brooks; J A Faulkner
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

5.  Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration.

Authors:  Robyn Meech; Katie N Gonzalez; Marietta Barro; Anastasia Gromova; Lizhe Zhuang; Julie-Ann Hulin; Helen P Makarenkova
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

6.  SMASH - semi-automatic muscle analysis using segmentation of histology: a MATLAB application.

Authors:  Lucas R Smith; Elisabeth R Barton
Journal:  Skelet Muscle       Date:  2014-11-27       Impact factor: 4.912

7.  IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.

Authors:  S Armando Villalta; Bo Deng; Chiara Rinaldi; Michelle Wehling-Henricks; James G Tidball
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

8.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

9.  Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice.

Authors:  D A Williams; S I Head; G S Lynch; D G Stephenson
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

Review 10.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.